As of 2026-05-03, the Relative Valuation of Insmed Inc (INSM) is (74.97) USD. This relative valuation is based on P/E multiples. With the latest stock price at 133.26 USD, the upside of Insmed Inc based on Relative Valuation is -156.3%.
The range of the Relative Valuation is (59.62) - (85.53) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.3x - 14.5x | 10.4x |
| Forward P/E multiples | 10.1x - 19.8x | 14.9x |
| Fair Price | (59.62) - (85.53) | (74.97) |
| Upside | -144.7% - -164.2% | -156.3% |
| Date | P/E |
| 2026-05-01 | -22.53 |
| 2026-04-30 | -23.05 |
| 2026-04-29 | -22.83 |
| 2026-04-28 | -22.81 |
| 2026-04-27 | -22.99 |
| 2026-04-24 | -22.85 |
| 2026-04-23 | -24.32 |
| 2026-04-22 | -24.43 |
| 2026-04-21 | -23.83 |
| 2026-04-20 | -24.14 |
| 2026-04-17 | -24.43 |
| 2026-04-16 | -24.14 |
| 2026-04-15 | -24.81 |
| 2026-04-14 | -25.93 |
| 2026-04-13 | -25.55 |
| 2026-04-10 | -26.17 |
| 2026-04-09 | -26.98 |
| 2026-04-08 | -27.08 |
| 2026-04-07 | -27.56 |
| 2026-04-06 | -27.69 |
| 2026-04-02 | -27.46 |
| 2026-04-01 | -27.87 |
| 2026-03-31 | -27.64 |
| 2026-03-30 | -25.92 |
| 2026-03-27 | -24.56 |
| 2026-03-26 | -24.95 |
| 2026-03-25 | -25.07 |
| 2026-03-24 | -23.52 |
| 2026-03-23 | -24.34 |
| 2026-03-20 | -22.99 |
| 2026-03-19 | -24.34 |
| 2026-03-18 | -24.12 |
| 2026-03-17 | -24.33 |
| 2026-03-16 | -24.45 |
| 2026-03-13 | -23.58 |
| 2026-03-12 | -23.59 |
| 2026-03-11 | -23.57 |
| 2026-03-10 | -24.32 |
| 2026-03-09 | -24.20 |
| 2026-03-06 | -23.69 |
| 2026-03-05 | -24.27 |
| 2026-03-04 | -25.34 |
| 2026-03-03 | -24.85 |
| 2026-03-02 | -24.74 |
| 2026-02-27 | -25.25 |
| 2026-02-26 | -25.36 |
| 2026-02-25 | -25.12 |
| 2026-02-24 | -26.82 |
| 2026-02-23 | -26.89 |
| 2026-02-20 | -27.88 |